Impact of Tumor

LINE-1 colorectal cancer methylation survival tumor

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
11 Nov 2020
Historique:
received: 01 10 2020
revised: 26 10 2020
accepted: 09 11 2020
entrez: 14 11 2020
pubmed: 15 11 2020
medline: 15 11 2020
Statut: epublish

Résumé

Recent studies suggest that long-interspersed nucleotide element-1 (

Identifiants

pubmed: 33187096
pii: jpm10040219
doi: 10.3390/jpm10040219
pmc: PMC7712476
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Cancer Med. 2020 Jan;9(1):361-373
pubmed: 31693304
Clin Chim Acta. 2019 Jan;488:209-214
pubmed: 30445031
Oncotarget. 2016 Aug 23;7(34):55098-55109
pubmed: 27391152
Clin Epigenetics. 2016 Apr 05;8:36
pubmed: 27051466
Br J Cancer. 2013 Jul 23;109(2):408-15
pubmed: 23764749
Nat Rev Genet. 2009 Oct;10(10):691-703
pubmed: 19763152
Int J Clin Oncol. 2017 Aug;22(4):749-757
pubmed: 28343299
Dis Markers. 2019 Mar 3;2019:2673543
pubmed: 30944663
PLoS One. 2011 Apr 14;6(4):e18884
pubmed: 21533144
J Clin Endocrinol Metab. 2015 Apr;100(4):E591-5
pubmed: 25706239
J Natl Cancer Inst. 2014 Sep 04;106(9):
pubmed: 25190725
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
J Clin Med. 2019 Jul 17;8(7):
pubmed: 31319558
Oncogene. 2010 Oct 28;29(43):5775-84
pubmed: 20562909
Int J Mol Sci. 2016 Dec 27;18(1):
pubmed: 28035987
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7535-E7544
pubmed: 27821766
Transl Res. 2017 Nov;189:76-92
pubmed: 28644958
J Proteomics Bioinform. 2018;11(6):120-126
pubmed: 30034186
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
PLoS One. 2018 May 24;13(5):e0197681
pubmed: 29795620
Cancers (Basel). 2019 Oct 24;11(11):
pubmed: 31652933
Mol Cell Biol. 2001 Mar;21(6):1973-85
pubmed: 11238933
Oncotarget. 2017 Feb 14;8(7):11906-11916
pubmed: 28060757

Auteurs

Hatim Boughanem (H)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Institute of Biomedical Research in Malaga (IBIMA), University of Malaga, 29016 Malaga, Spain.

Gracia María Martin-Nuñez (GM)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Institute of Biomedical Research in Malaga (IBIMA), University of Malaga, 29016 Malaga, Spain.
CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Esperanza Torres (E)

Unidad de Gestión Clínica de Oncología Intercentros Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.

Isabel Arranz-Salas (I)

UGC de Anatomía Patológica, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.

Julia Alcaide (J)

Medical Oncology Service, Hospital Costa del Sol, Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), 29603 Marbella, Spain.

Sonsoles Morcillo (S)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Institute of Biomedical Research in Malaga (IBIMA), University of Malaga, 29016 Malaga, Spain.
CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Francisco J Tinahones (FJ)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Institute of Biomedical Research in Malaga (IBIMA), University of Malaga, 29016 Malaga, Spain.
CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Ana B Crujeiras (AB)

CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Epigenomics in Endocrinology and Nutrition Group, Instituto de Investigación Sanitaria (IDIS), Complejo Hospitalario Universitario de Santiago (CHUS/SERGAS), 15706 Santiago de Compostela, Spain.

Manuel Macias-Gonzalez (M)

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Institute of Biomedical Research in Malaga (IBIMA), University of Malaga, 29016 Malaga, Spain.
CIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Classifications MeSH